The Cayey Toritos pray before their home opener in Aibonito, Puerto Rico. Photograph: Dennis M Rivera Pichardo/The New York Times

At the Estadio Hermanos Marrero, a baseball stadium nestled in this small, mountainous municipality in the centre of Puerto Rico, parts of the roof ov(...)

The acquisition is the latest in a spate of big pharma deals this year as many companies are strengthening their portfolios as old drugs go generic

AbbVie is to buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expan(...)

The very Shire executives who baulked at the original acquisition proposal are demanding Abbvie follow through on its takeover while Abbvie is widely expected to withdraw a recommendation to its own shareholders to back the deal when its board meets on Monday.  Photograph: Aidan Crawley/Bloomberg

Cantillon: US biopharmaceuticals group Abbvie is in danger of proving the Obama administration and its truculent Congress right. Its increasing reluct(...)

Dublin-headquartered Shire stands to be paid a break-up fee of about $1.64 billion if Abbvie’s shareholders vote against the deal

US pharmaceutical company AbbVie has recommended that shareholders vote against its $55 billion takeover of Dublin-headquartered Shire in the wake of(...)

 To woo Shire, the US biopharmaceutical  company AbbVie trod cautiously in takeover bid. Photo: Bloomberg

Susan Kilsby had not been chairwoman of the drugmaker Shire for even a week when she received an office call that would set off a frenzied trans-Atlan(...)

US drugmaker AbbVie has been forced to retract comments by its chief executive about shareholder support for its bid for Shire after being caught out(...)

AbbVie increased its offer by about 11 per cent to £51.15 a share in cash and stock after meeting with Shire’s top shareholders, the drugmaker said today. Photographer: Simon Dawson/Bloomberg

US pharma group AbbVie made a fourth offer to buy Irish-headquartered rare drug company Shire, raising the price to about £30.1 billion (€38 billion) (...)

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire . Photographer: JB Reed/Bloomberg News

US drugmaker AbbVie raised its offer for Shire to £51.15 a share on Tuesday, hoping to win over its reluctant target after an earlier offer was rejec(...)

 AbbVie, in its pursuit of drugmaker Shire, has hired some of the same advisers that Pfizer worked with in its failed push for AstraZeneca. Photo: Bloomberg

AbbVie, in its pursuit of drugmaker Shire, has hired some of the same advisers that Pfizer worked with in its failed push for AstraZeneca. Richard G(...)

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire . Photographer: JB Reed/Bloomberg News

Shire, which has spurned a $46 billion takeover offer from US group AbbVie as inadequate, has a new reason to argue it is worth more after a US court (...)